Literature DB >> 16726985

Induction of synchronized estrus and fertility in anestrous ZebuxTaurus crossbred cows.

A V Narasimha Rao1, T B Suryaprakasam.   

Abstract

A major cause for reproductive failures in Zebu x Taurine crossbred cows is postpartum anestrus. Crossbred cows were diagnosed to be in postpartum anestrus by palpation per rectum of nonfunctional ovaries. To induce synchronized estrus, the cows were treated by placement of a progesterone releasing intravaginal device (PRID) for various number of days, together with a single administration of prostaglandin F2 alpha (PGF, 5 mg intravulvosubmucos), estradiol-17beta (E2, 1 mg i.m.) or pregnant mare serum gonadotrophin (PMSG, 500 IU i.m.). Administration of PRID for 7 d, and of E2 and PMSG on Day 6, significantly improved the degree of behavioral estrus manifestation compared to single PRID for 12 d or PRID for 7 d, and of PGF on Day 6. However, the treatment combination of PRID and PMSG alone was associated with higher (P<0.01) conception rate to 2 fixed time A.I. at induced estrus. The mean interval from treatment to conception was also shortest (P<0.01) for this group. These results suggest that administration of PRID for 7 d, and of PMSG on Day 6 is highly effective in achieving synchronized behavioural estrus, a near normal CR to fixed time A.I. and a shorter interval from treatment to conception in anestrus ZebuxTaurine crossbred cows under Indian field conditions.

Entities:  

Year:  1991        PMID: 16726985     DOI: 10.1016/0093-691x(91)90441-f

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  1 in total

1.  Treatment with an intravaginal progestagen and estradiol to prevent prolonged anestrus in crossbred zebu cows under tropical conditions.

Authors:  R A Palomares-Naveda; G Portillo-Martinez; J C Gutierrez-Añez; A De Ondiz-Sanchez; J Goicochea-Llaque; R Gonzalez-Fernandez; F Perea-Ganchou; E Soto-Belloso
Journal:  Trop Anim Health Prod       Date:  2008-01       Impact factor: 1.559

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.